Brief: Idera Pharmaceuticals Reports Fourth Quarter Financial Results

Aceragen

06/03/2019 22:09

March 6 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR END
2018
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * Q4 LOSS PER SHARE $0.45
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.51 -- REFINITIV IBES
DATA
    * AS OF DECEMBER 31, 2018, OUR CASH AND CASH EQUIVALENTS
TOTALED
$71.4 MILLION COMPARED TO $112.6 MILLION AS OF DECEMBER 31, 2017
    * ILLUMINATE-206 TRIAL EXPECTED TO INITIATE Q2 2019
    * CURRENTLY ANTICIPATE EXISTING CASH, CASH EQUIVALENTS AND
INVESTMENTS WILL FUND OPERATIONS INTO Q1 OF 2020

Source text for Eikon:  ID:nGNX8LF18P 
Further company coverage:  IDRA.O 

 ((Briefs@thomsonreuters.com;))